It’s clear you haven’t looked through the AR. There’s a valuable...

It’s clear you haven’t looked through the AR. There’s a valuable debt free facility sitting there bringing in $500k p/year and looking at R&D expenses, another $1m or $2m on the way from the refund which I haven’t seen in the cash flow updates yet. I’d hazard a guess by saying the Company would be snapped before raising at these levels. Unless successful results on R&D give it a rerate. Both of which would come with hefty premiums.. Not many other Companies on the ASX with net asset backing higher than the share price, with products now at registration